TRIPAWDS: Home to 20815 Members and 2043 Blogs.
HOME » NEWS » BLOGS » FORUMS » CHAT » YOUR PRIVACY » RANDOM BLOG
All sites currently ad-free!

Caring for a Three Legged Dog or Cat

Tripawds is the place to learn how to care for a three legged dog or cat, with answers about dog leg amputation, and cat amputation recovery from many years of member experiences.
JUMP TO FORUMS

Join The Tripawds Community

Learn how to help three legged dogs and cats in the forums below. Browse and search as a guest or register for free and get full member benefits:

  • Instant post approval.
  • Private messages to members.
  • Subscribe to favorite topics.
  • Live Chat and much more!

REGISTER   |   LOG IN

Please consider registering
Guest
Search
Forum Scope


Match



Forum Options



Minimum search word length is 3 characters - maximum search word length is 84 characters
Register Lost password?
sp_Feed sp_PrintTopic sp_TopicIcon-c
University of Minnesota: Canine Cancer Clinical Trials
sp_NewTopic Add Topic
On The Road


Member Since:
24 September 2009
sp_UserOfflineSmall Offline
1
8 July 2014 - 8:43 pm
sp_Permalink sp_Print sp_QuotePost

Just came across these two interesting trials going on:

Compassionate Use of TTG100 in Canine Cancer

Current Status: Active and enrolling
Principal Investigator: Mike Henson, DVM, PhD, DACVIM
Contacts:
Dr. Henson: henso001@umn.edu
Amber Winter, study technician: 612-624-1352 or alwinter@umn.edu
Oncology service at 612-626-8387 (main VMC number) 

TTG100 is a new drug in a class of drugs which may be effective against a variety of types of cancer in dogs. In particular, we are seeking Bernese Mountain dogs and Golden Retrievers with histiocytic sarcoma. We may be able to treat other breeds and other cancers as well. The study involves an oral drug given at home, with five visits to the Veterinary Medical Center over a 3-4 month period.

Owners will be responsible for the costs of the visits. However, thanks to our generous donors, we can offer a $1,000 credit to owners to help with costs, paid as $500 at enrollment and $500 at the conclusion of the study.

Hypoxyprobe study (Bone Biopsy)

Current Status: Active and enrolling
Principal Investigator: Sara Fritz, DVM
Contacts:
Dr. Sara Fritz: 612-626-4333 or sefritz@umn.edu
Amber Winter, study technician: 612-624-1352 or alwinter@umn.edu
Oncology service at 612-626-8387 (main VMC number)

This pilot study will use a new technique to visualize hypoxic, or low oxygen, areas of a bone biopsy taken from dogs with suspected osteosarcoma (OSA). Oxygen gradients exist in normal and tumor tissue. These gradients affect the cells at the genetic level and are important in normal and abnormal conditions. Until recently it was difficult to measure these gradients at the cellular level but Hypoxyprobe-1 (pimonidazole HCL) has made this possible. If scientists can understand these areas in tumors they may be able to develop treatments for  these tumors in the future.

We are looking for dogs scheduled to have a bone biopsy at the Veterinary Medical Center (VMC). Owners who consent to this study will bring their dog the day before the biopsy to receive one intravenous (IV) treatment of Hypoxyprobe-1. Dogs will stay overnight for observation.

The study will cover the cost of the hypoxyprobe and the overnight stay in the hospital.

Tripawds Founders Jim and Rene
tripawds.com | tripawds.org | bemoredog.net | triday.pet

Forum Timezone: America/Denver
Most Users Ever Online: 946
Currently Online: Tonya Holcomb
Guest(s) 87
Currently Browsing this Page:
1 Guest(s)
Member Stats:
Guest Posters: 1213
Members: 15721
Moderators: 2
Admins: 3
Forum Stats:
Groups: 4
Forums: 23
Topics: 17761
Posts: 246921
Administrators: admin, jerry, Tripawds
Moderators: betaman, krun15
Tripawds is brought to you by Tripawds.
HOME » NEWS » BLOGS » FORUMS » CHAT » YOUR PRIVACY » RANDOM BLOG
All sites currently ad-free!